SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029779
Filing Date
2020-10-29
Accepted
2020-10-29 20:45:27
Documents
2
Period of Report
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1524
2 EX-24 DOCUMENT attachment1.htm EX-24 4318
  Complete submission text file 0000899243-20-029779.txt   7222
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATEA PHARMACEUTICALS, INC. 125 SUMMER STREET BOSTON MA 02110
Business Address
Cheng Isaac (Reporting) CIK: 0001829696 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 201274374